Percutaneous cholecystostomy in elderly patients with acute cholecystitis: Factors influencing mortality, morbidity, and length of hospital stay
Turkish Journal of Trauma and Emergency Surgery · 2025
DOI: 10.14744/tjtes.2024.94489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Trauma and Emergency Surgery, 2025. Verfasst von Emre Teke und 7 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, University of Health Sciences, Gaziantep City Hospital, Gaziantep-Türkiye. Hauptthemen laut MEDLINE: Cholecystitis, Acute, Cholecystostomy, Length of Stay. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Acute cholecystitis (AC) is increasingly common and imposes a burden on healthcare systems, particularly in the elderly population. While laparoscopic cholecystectomy (LC) is the definitive treatment, percutaneous cholecystostomy (PC) is often preferred based on various factors. The treatment of elderly patients requires a multidisciplinary approach that carefully assesses surgical risks due to age-related changes and comorbidities. This retrospective study evaluates factors affecting mortality, morbidity, and hospital stay in elderly patients diagnosed with AC who presented to the emergency department and underwent PC. METHODS: This retrospective study, conducted between January 2013 and January 2021, included patients aged 70 years and older with grade 2 and 3 AC, as classified by the Tokyo Guidelines, who underwent PC. Data on laboratory parameters, comorbidities, and outcomes were collected and analyzed. RESULTS: Among the 76 included patients, complications occurred in 7.9% of cases, with catheter replacement being the most common complication. In-hospital mortality was 5.2%. Factors influencing hospital stay included intervention timing and serum albumin levels. Placement of percutaneous cholecystostomy within the first three days of hospitalization has been shown to shorten the length of hospital stay. CONCLUSION: Personalized treatment strategies are essential for managing AC in elderly patients. Early placement of PC may reduce hospital stays and associated costs. Further research and updated guidelines are necessary to optimize outcomes in this demographic group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- General Surgery Department, University of Health Sciences, Gaziantep City Hospital, Gaziantep-Türkiye.
- General Surgery Department, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul-Türkiye.
- Anesthesiology and Reanimation Department, University of Health Sciences, Gaziantep City Hospital, Gaziantep-Türkiye.
- General Surgery Department, University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum-Türkiye.
- Interventional Radiology Department, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul-Türkiye.
Zitieren
APA
Teke, E., Agca, B., Güneş, Y., Teke, G. N., Yaz, A. S., Aydin, M. T., Başak, A., & Yıldırım, G. (2025). Percutaneous cholecystostomy in elderly patients with acute cholecystitis: Factors influencing mortality, morbidity, and length of hospital stay. Turkish Journal of Trauma and Emergency Surgery. https://doi.org/10.14744/tjtes.2024.94489
Vancouver
Teke E, Agca B, Güneş Y, Teke GN, Yaz AS, Aydin MT, et al. Percutaneous cholecystostomy in elderly patients with acute cholecystitis: Factors influencing mortality, morbidity, and length of hospital stay. Turkish Journal of Trauma and Emergency Surgery. 2025. doi:10.14744/tjtes.2024.94489
BibTeX
@article{Teke2025,
author = {Teke, Emre and Agca, Birol and Güneş, Yasin and Teke, Gamze Nur and Yaz, Ahmet Said and Aydin, M Timucin and Başak, Ahmet and Yıldırım, Gülşah},
title = {Percutaneous cholecystostomy in elderly patients with acute cholecystitis: Factors influencing mortality, morbidity, and length of hospital stay},
journal = {Turkish Journal of Trauma and Emergency Surgery},
year = {2025},
doi = {10.14744/tjtes.2024.94489}
}
EUVIMED